CRSP logo

CRSP
CRISPR Therapeutics AG

41,705
Mkt Cap
$5.78B
Volume
1.69M
52W High
$78.48
52W Low
$30.04
PE Ratio
-9.23
CRSP Fundamentals
Price
$60.14
Prev Close
$61.74
Open
$59.50
50D MA
$54.16
Beta
1.53
Avg. Volume
1.84M
EPS (Annual)
-$6.47
P/B
3.00
Rev/Employee
$8,931.30
$2,938.96
Loading...
Loading...
News
all
press releases
HighTower Advisors LLC Reduces Stake in CRISPR Therapeutics AG $CRSP
HighTower Advisors LLC lessened its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP - Free Report) by 58.4% during the 3rd quarter, according to the company in its most recent filing with the...
MarketBeat·3h ago
News Placeholder
More News
News Placeholder
JPMorgan Chase & Co. Buys 294,222 Shares of CRISPR Therapeutics AG $CRSP
JPMorgan Chase & Co. raised its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP - Free Report) by 98.3% in the 3rd quarter, according to its most recent 13F filing with the Securities...
MarketBeat·1d ago
News Placeholder
CRISPR Therapeutics (NASDAQ:CRSP) Shares Up 11.2% - Still a Buy?
CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Up 11.2% - Should You Buy...
MarketBeat·3d ago
News Placeholder
CRISPR Therapeutics AG (NASDAQ:CRSP) Given Consensus Recommendation of "Hold" by Brokerages
CRISPR Therapeutics AG (NASDAQ:CRSP - Get Free Report) has been given an average rating of "Hold" by the eighteen analysts that are covering the stock, Marketbeat reports. Two equities research...
MarketBeat·3d ago
News Placeholder
Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026
Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026 Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026 PR Newswire VANCOUVER, BC, Feb. 25, 2026...
PR Newswire·4d ago
News Placeholder
Versant Venture Management LLC Decreases Holdings in CRISPR Therapeutics AG $CRSP
Versant Venture Management LLC cut its holdings in shares of CRISPR Therapeutics AG (NASDAQ:CRSP - Free Report) by 70.1% in the 3rd quarter, according to its most recent disclosure with the...
MarketBeat·5d ago
News Placeholder
Cathie Wood buys $3.5 million in Nvidia-backed stock ahead of earnings
Cathie Wood just dropped a head-turning $3.46 million bet on CoreWeave (CRWV) stock just days before a critical earnings report.ARK Invest scooped up 35,612 shares of the popular Nvidia-backed AI...
TheStreet.com·6d ago
News Placeholder
O Neil Global Advisors Inc. Acquires Shares of 168,715 CRISPR Therapeutics AG $CRSP
O Neil Global Advisors Inc. bought a new position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP - Free Report) in the third quarter, according to the company in its most recent Form 13F filing...
MarketBeat·6d ago
News Placeholder
Vestmark Advisory Solutions Inc. Has $15.49 Million Stake in CRISPR Therapeutics AG $CRSP
Vestmark Advisory Solutions Inc. trimmed its stake in CRISPR Therapeutics AG (NASDAQ:CRSP - Free Report) by 50.7% during the third quarter, according to its most recent 13F filing with the SEC. The...
MarketBeat·7d ago
News Placeholder
CRISPR Therapeutics (NASDAQ:CRSP) CEO Samarth Kulkarni Sells 6,967 Shares
CRISPR Therapeutics AG (NASDAQ:CRSP - Get Free Report) CEO Samarth Kulkarni sold 6,967 shares of the stock in a transaction on Thursday, February 19th. The stock was sold at an average price of...
MarketBeat·8d ago
<
1
2
...
>

Latest CRSP News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.